title: New technologies for patients with end-stage renal disease: the US regulatory perspective.
authors.affiliation: US Food and Drug Administration, Center for Devices and Radiological Health, Office of Device Evaluation, Division of Reproductive, Abdominal, and Radiological Devices, Gastroenterology and Renal Devices Branch, Rockville, Md., USA. mxp@cdrh.fda.gov
authors.forename: M C
authors.initials: MC
authors.lastname: Provost
authors.forename: C M
authors.initials: CM
authors.lastname: Meyers
mesh_terms: D018795:Device Approval; D004864:Equipment and Supplies; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D006435:Renal Dialysis / Q000295:instrumentation*; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence